Schulz Tim, Pries Alexandra, Caliebe Amke, Kapischke Matthias
Department of General Surgery, Siloah St. Trudpert Klinikum, Pforzheim, Germany.
Ethics Commitee, University Hospital of Schleswig-Holstein, Kiel, Germany.
Ann Transplant. 2014 Feb 28;19:106-11. doi: 10.12659/AOT.889715.
Simultaneous pancreas-kidney transplantation has been established as the treatment of choice for type 1 diabetes patients with renal dysfunction. Patient 1-year survival better than 95% has been achieved using this kind of transplantation. According to the postoperative complication rate (5% mortality), recipients appear to have a survival benefit not earlier than 2 years after transplantation. This study evaluates the long-term benefit of simultaneous pancreas-kidney recipients with functioning grafts after 1 year.
MATERIAL/METHODS: A retrospective analysis of 176 patients after first transplantation with functioning grafts 1 year after simultaneous pancreas-kidney transplantation was performed.
During the follow-up period starting 1 year after successful transplantation, 7 patients died due to various causes, 13 pancreas grafts (7.4%) and 13 kidney transplants (7.4%) lost their function during the 10-year follow-up period. Chronic graft failure was the most common reason for transplant loss.
Our data support the excellent long-term prognosis of simultaneous pancreas-kidney transplantation recipients with functioning graft 1 year after transplantation.
胰肾联合移植已被确立为患有肾功能不全的1型糖尿病患者的首选治疗方法。通过这种移植方式,患者1年生存率已超过95%。根据术后并发症发生率(死亡率为5%),受者似乎在移植后不少于2年才有生存获益。本研究评估了胰肾联合移植术后1年移植物功能良好的受者的长期获益情况。
材料/方法:对176例胰肾联合移植术后1年移植物功能良好的首次移植患者进行回顾性分析。
在成功移植1年后开始的随访期内,7例患者因各种原因死亡,13个胰腺移植物(7.4%)和13个肾移植移植物(7.4%)在10年随访期内失去功能。慢性移植物失功是移植失败的最常见原因。
我们的数据支持胰肾联合移植术后1年移植物功能良好的受者具有良好的长期预后。